Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalating Study to Evaluate Pharmacokinetics, Efficacy and Safety of Apotransferrin in Atransferrinemia Patients

NCT01797055 is registered in ClinicalTrials.gov with Prothya Biosolutions as lead sponsor.

NCT NCT01797055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01797055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalating Study to Evaluate Pharmacokinetics, Efficacy and Safety of Apotransferrin in Atransferrinemia Patients
Lead sponsor
Prothya Biosolutions
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 31, 2010
Completion date
January 31, 2028
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

congenital atransferrinemia